IOMX Trademark

Trademark Overview

On Thursday, November 10, 2016, a trademark application was filed for IOMX with the United States Patent and Trademark Office. The USPTO has given the IOMX trademark a serial number of 87232206. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Thursday, January 16, 2025. This trademark is owned by IOmx Therapeutics AG. The IOMX trademark is filed in the Computer & Software Services & Scientific Services and Pharmaceutical Products categories with the following description:

[ Pharmaceutical preparations and therapeutic preparations in the nature of medications and therapeutic pharmaceuticals for the prevention and treatment of cancer ]

Research and development of pharmaceutical and therapeutic preparations in the field of oncology
iomx

General Information

Serial Number87232206
Word MarkIOMX
Filing DateThursday, November 10, 2016
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 16, 2025
Registration Number5410122
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and Services[ Pharmaceutical preparations and therapeutic preparations in the nature of medications and therapeutic pharmaceuticals for the prevention and treatment of cancer ]
Goods and ServicesResearch and development of pharmaceutical and therapeutic preparations in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 16, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateThursday, January 16, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIOmx Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPlanegg/Martinsried 82152
DE
Party NameIOmx Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlanegg/Martinsried 82152
DE
Party NameIOmx Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlanegg/Martinsried 82152
DE

Trademark Events

Event DateEvent Description
Thursday, February 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 14, 2016NEW APPLICATION ENTERED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 16, 2017ASSIGNED TO EXAMINER
Thursday, February 16, 2017NON-FINAL ACTION E-MAILED
Thursday, February 16, 2017NON-FINAL ACTION WRITTEN
Wednesday, June 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 20, 2017ASSIGNED TO LIE
Friday, July 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 12, 2017FINAL REFUSAL WRITTEN
Saturday, July 22, 2017NON-FINAL ACTION WRITTEN
Saturday, July 22, 2017NON-FINAL ACTION E-MAILED
Saturday, July 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2017FINAL REFUSAL E-MAILED
Thursday, October 12, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Friday, April 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 23, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 16, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 16, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 16, 2025REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

iomx preparations therapeutic pharmaceutical research development oncology cancer field prevention nature